VIP and COVID-19: In an independent cohort (Cohort 2, n = 20, Supplementary Data 1; Fig. 1e) prospectively enrolled in the current study after the onset of the COVID-19 pandemic, the ViP signatures could differentiate the acute from subacute (~10–14 d after discharge; ~day 17–25 of Illness) KD samples.